The novel class of GLP-1 agonist medication and GIP combined medications, including tirzepatide, semaglutide, and the recently introduced retatrutide, represent significant advances in metabolic management . https://mots-c-peptide983874.polarisnewsblog.com/956284/semaglutide-a-detailed-examination